R&D News | pharmaphorum

News

Strong phase 3 results for Moderna's individualised skin cancer vaccine could pave the way for a leap forward in the field.

News

Network Bio launched today with $50 million in financing. It has also announced a collaboration with NVIDIA.

News

LEO Pharma is betting up to $435m on a pill that could give people with an ultra-rare light sensitivity disorder a way to spend more time outdoors.

News

BioMarin will acquire Alesta's experimental therapy for rare bone disease hypophosphatasia for up to $490 million.

News

Hansa has announced that the first commercial patient in Australia has received a living donor kidney transplant following treatment with Idefirix.

News

Following the failure of its sickle cell programme, Fulcrum Therapeutics will merge with Slate Medicines to advance Slate's migraine therapy.